+

WO2006031420A3 - Comprimes multicouche et formes posologiques bioadhesives - Google Patents

Comprimes multicouche et formes posologiques bioadhesives Download PDF

Info

Publication number
WO2006031420A3
WO2006031420A3 PCT/US2005/030651 US2005030651W WO2006031420A3 WO 2006031420 A3 WO2006031420 A3 WO 2006031420A3 US 2005030651 W US2005030651 W US 2005030651W WO 2006031420 A3 WO2006031420 A3 WO 2006031420A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug
layer tablets
dosage form
retention time
dosage forms
Prior art date
Application number
PCT/US2005/030651
Other languages
English (en)
Other versions
WO2006031420A2 (fr
Inventor
Avinash Nangia
Jules Jacob
Edith Mathiowitz
Thomas L Ricketts
Mark R Kreitz
Original Assignee
Spherics Inc
Avinash Nangia
Jules Jacob
Edith Mathiowitz
Thomas L Ricketts
Mark R Kreitz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/009,327 external-priority patent/US20050201974A1/en
Priority claimed from PCT/US2005/007525 external-priority patent/WO2005084639A2/fr
Application filed by Spherics Inc, Avinash Nangia, Jules Jacob, Edith Mathiowitz, Thomas L Ricketts, Mark R Kreitz filed Critical Spherics Inc
Priority to AU2005285298A priority Critical patent/AU2005285298A1/en
Priority to US11/661,541 priority patent/US20080311191A1/en
Priority to EP05792519A priority patent/EP1784167A2/fr
Priority to JP2007530225A priority patent/JP2008516893A/ja
Priority to CA002578845A priority patent/CA2578845A1/fr
Publication of WO2006031420A2 publication Critical patent/WO2006031420A2/fr
Publication of WO2006031420A3 publication Critical patent/WO2006031420A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des enrobages bioadhésifs qui augmentent le temps de séjour gastro-intestinal de médicaments ingérés par voie orale. Certains enrobages bioadhésifs possèdent une résistance à la rupture d'au moins 100 N/m2, mesurée sur un intestin de rat, lorsqu'ils sont appliqués sur une surface d'une forme posologique pharmaceutique destinée à l'administration d'un médicament par voie orale. Cette caractéristique permet d'obtenir un temps de séjour gastro-intestinal d'au moins 4 jours chez un chien de race beagle qui est alimenté, période durant laquelle le médicament est libéré par la forme posologique. L'invention concerne également des comprimés multicouche, en particulier ceux contenant des excipients hydrophobes, pouvant être utilisés pour administrer des médicaments hygroscopes et/ou déliquescents. Par ailleurs, en variant la concentration de médicament dans les comprimés multicouche, on régule la vitesse de libération du médicament.
PCT/US2005/030651 2004-08-27 2005-08-29 Comprimes multicouche et formes posologiques bioadhesives WO2006031420A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU2005285298A AU2005285298A1 (en) 2004-08-27 2005-08-29 Multi-layer tablets and bioadhesive dosage forms
US11/661,541 US20080311191A1 (en) 2004-08-27 2005-08-29 Multi-Layer Tablets and Bioadhesive Dosage Forms
EP05792519A EP1784167A2 (fr) 2004-08-27 2005-08-29 Comprimes multicouche et formes posologiques bioadhesives
JP2007530225A JP2008516893A (ja) 2004-08-27 2005-08-29 多層錠剤および生体接着性剤形
CA002578845A CA2578845A1 (fr) 2004-08-27 2005-08-29 Comprimes multicouche et formes posologiques bioadhesives

Applications Claiming Priority (26)

Application Number Priority Date Filing Date Title
US60519804P 2004-08-27 2004-08-27
US60520104P 2004-08-27 2004-08-27
US60499004P 2004-08-27 2004-08-27
US60499104P 2004-08-27 2004-08-27
US60519904P 2004-08-27 2004-08-27
US60520004P 2004-08-27 2004-08-27
US60/604991 2004-08-27
US60/605201 2004-08-27
US60/605199 2004-08-27
US60/605200 2004-08-27
US60/605198 2004-08-27
US60/604990 2004-08-27
US60790504P 2004-09-08 2004-09-08
US60/607905 2004-09-08
US11/009,327 US20050201974A1 (en) 2003-12-09 2004-12-09 Bioadhesive polymers with catechol functionality
US11/009,327 2004-12-09
US63581204P 2004-12-13 2004-12-13
US60/635812 2004-12-13
US65037505P 2005-02-04 2005-02-04
US65019105P 2005-02-04 2005-02-04
US60/650375 2005-02-04
US60/650191 2005-02-04
USPCT/US2005/007525 2005-03-03
PCT/US2005/007525 WO2005084639A2 (fr) 2004-03-03 2005-03-03 Systeme d'administration de medicaments polymeres pour des medicaments hydrophobes
US67638305P 2005-04-29 2005-04-29
US60/676383 2005-04-29

Publications (2)

Publication Number Publication Date
WO2006031420A2 WO2006031420A2 (fr) 2006-03-23
WO2006031420A3 true WO2006031420A3 (fr) 2006-11-30

Family

ID=35703299

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/030651 WO2006031420A2 (fr) 2004-08-27 2005-08-29 Comprimes multicouche et formes posologiques bioadhesives

Country Status (4)

Country Link
EP (1) EP1784167A2 (fr)
AU (1) AU2005285298A1 (fr)
CA (1) CA2578845A1 (fr)
WO (1) WO2006031420A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007103286A2 (fr) * 2006-03-02 2007-09-13 Spherics, Inc. Formulations posologiques orales a liberation controlee
EP2942053A1 (fr) 2007-07-06 2015-11-11 Lupin Limited Compositions pharmaceutiques pour administration gastro-intestinale de médicaments
US20120027855A1 (en) 2007-07-06 2012-02-02 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
WO2009008006A2 (fr) * 2007-07-06 2009-01-15 Lupin Limited Compositions pharmaceutiques d'administration gastro-intestinale de médicaments
JP2013169146A (ja) * 2012-02-17 2013-09-02 Kabaya Shokuhin Kk 新規清涼菓子およびその製造方法
TWI439288B (zh) * 2012-10-05 2014-06-01 Univ China Medical 藥用載體及其製備方法與用途
WO2014059309A1 (fr) * 2012-10-11 2014-04-17 Theravida, Inc. Formulations pharmaceutiques de pilocarpine
WO2015167434A1 (fr) * 2014-04-28 2015-11-05 Eduardo Fernandez Compositions pour la supplémentation nutritionnelle
CN114177155B (zh) * 2020-09-08 2023-10-03 越洋医药开发(广州)有限公司 一种布洛芬控释片及其制备方法
CN116159037B (zh) * 2023-04-25 2023-08-01 四川省川龙动科药业有限公司 一种防治仔猪结肠炎的靶向微丸组合物及其制备方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000112A1 (fr) * 1992-06-24 1994-01-06 Astra Aktiebolag Formulation orale destinee au traitement antibacterien gastrique, procede de preparation et d'utilisation de cette formulation
US6123965A (en) * 1996-01-26 2000-09-26 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US6156348A (en) * 1996-06-25 2000-12-05 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
US6197346B1 (en) * 1992-04-24 2001-03-06 Brown Universtiy Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
WO2002005820A1 (fr) * 2000-07-19 2002-01-24 Lavipharm Laboratories, Inc. Dispersions solides de citrate de sildenafil ayant une forte solubilite dans l'eau
US6391335B1 (en) * 1998-04-29 2002-05-21 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6391294B1 (en) * 1997-08-21 2002-05-21 Reckitt Benckiser Healthcare (Uk) Limited In situ formation of polymeric material
US20030113371A1 (en) * 2001-08-21 2003-06-19 Council Of Scientific & Industrial Research Composition and method for maintaining blood glucose level by employing the hydrophilic matrix based oral controlled release antidiabetic composition

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197346B1 (en) * 1992-04-24 2001-03-06 Brown Universtiy Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
WO1994000112A1 (fr) * 1992-06-24 1994-01-06 Astra Aktiebolag Formulation orale destinee au traitement antibacterien gastrique, procede de preparation et d'utilisation de cette formulation
US6123965A (en) * 1996-01-26 2000-09-26 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US6156348A (en) * 1996-06-25 2000-12-05 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
US6391294B1 (en) * 1997-08-21 2002-05-21 Reckitt Benckiser Healthcare (Uk) Limited In situ formation of polymeric material
US6391335B1 (en) * 1998-04-29 2002-05-21 Cima Labs Inc. Effervescent drug delivery system for oral administration
WO2002005820A1 (fr) * 2000-07-19 2002-01-24 Lavipharm Laboratories, Inc. Dispersions solides de citrate de sildenafil ayant une forte solubilite dans l'eau
US20030113371A1 (en) * 2001-08-21 2003-06-19 Council Of Scientific & Industrial Research Composition and method for maintaining blood glucose level by employing the hydrophilic matrix based oral controlled release antidiabetic composition

Also Published As

Publication number Publication date
EP1784167A2 (fr) 2007-05-16
CA2578845A1 (fr) 2006-03-23
AU2005285298A1 (en) 2006-03-23
WO2006031420A2 (fr) 2006-03-23

Similar Documents

Publication Publication Date Title
WO2007031887A3 (fr) Composition pharmaceutique de metformine a liberation lente et procede de production correspondant
JP2005511647A (ja) 経口用および口内用の成型粉薬錠剤を伴う圧縮環状錠剤
WO2007009806A3 (fr) Formulations posologiques solides de medicaments narcotiques presentant une adsorption buccale amelioree
WO2007013975A3 (fr) Compositions et procedes destines a controler l'abus de medicaments
WO2007079082A3 (fr) Systeme gastrique a impulsions de liberation pour l'administration de medicaments
WO2007081948A3 (fr) Formulations de médicaments bioadhésifs pour administration par voie transmucosale orale
WO2008085765A3 (fr) Formes dosifiées de petit volume de médicament contenant du sufentanil s'administrant par voie trans-muqueuse orale pour le traitement de la douleur
WO2006063189A3 (fr) Systeme d'administration de medicament a desintegration rapide
PL211301B1 (pl) Tabletka wielowarstwowa dyspergowalna w ustach oraz sposób jej wytwarzania
WO2006039499A3 (fr) Procede d'amelioration de la biodisponibilite d'agents therapeutiques administres par voie orale
IL181382A0 (en) Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition
JP2009536147A5 (fr)
HK1111902A1 (en) Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof
IL205262A (en) Use of Risderdone Acid or its Pharmaceutical Salt to produce oral medication once a month for the prevention and treatment of osteoporosis
WO2006125819A3 (fr) Forme medicamenteuse orale, microparticulaire, anti-mesusage
EP1957110A4 (fr) Procede pour la fabrication de formes pharmaceutiques a macher pour l'administration de medicament et produits associes
WO2007122635A3 (fr) Formulation à libération à libération contrôlée comprenant des médicaments anti-épilepiques
CN107106498A (zh) 用于生产药物递送系统的方法
AU2004246837A1 (en) Orally-dispersible multilayer tablet
WO2006031420A3 (fr) Comprimes multicouche et formes posologiques bioadhesives
WO2005112896A3 (fr) Forme posologique permettant l'administration de multiples formes medicamenteuses
IL187632A (en) 17 – Ethinyl – 17 – Hydroxy – 13 – Methyl – 17,16,15,14,13,12,11,9,8,7 – Dachahydro – 6 h– Cyclopentane [a] Penanthran – 3 – Ilmethyl ester of acetoxy acid Acetic, a pharmaceutical dosage unit containing it and its use in the preparation of a contraceptive
WO2007086079A3 (fr) Forme de dose a liberation soutenue de derives de phenothiazine contenant un canalisateur
WO2007011958A3 (fr) Formes posologiques intra-buccales de glucagon
WO2006040779A3 (fr) Formule à matrice flottante gastrique à libération contrôlée contenant la substance imatinib

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007530225

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2578845

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2005285298

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2005792519

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2005285298

Country of ref document: AU

Date of ref document: 20050829

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005285298

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2005792519

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11661541

Country of ref document: US

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载